We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+13.23%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.71B
AUM Growth
+$351M
Cap. Flow
-$22.1M
Cap. Flow %
-0.6%
Top 10 Hldgs %
21.85%
Holding
5,705
New
584
Increased
2,919
Reduced
1,681
Closed
462

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$206M
2
META icon
Meta Platforms (Facebook)
META
+$37.5M
3
AMZN icon
Amazon
AMZN
+$35.5M
4
AVGO icon
Broadcom
AVGO
+$34.8M
5
MSFT icon
Microsoft
MSFT
+$29.8M

Sector Composition

Rank Sector Weight
1 Technology 20.47%
2 Financials 11.61%
3 Healthcare 8.42%
4 Industrials 6.72%
5 Consumer Discretionary 6.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANRO icon
4151
Alto Neuroscience
ANRO
$1.09B
$5.76K ﹤0.01%
2,618
-1,619
-38% -$3.85K
MSS icon
4152
Maison Solutions
MSS
$1.24M
$5.76K ﹤0.01%
130
+82
+171% +$3.88K
KEQU icon
4153
Kewaunee Scientific
KEQU
$104M
$5.75K ﹤0.01%
98
-253
-72% -$9.39K
KLRS
4154
Kalaris Therapeutics
KLRS
$94.5M
$5.75K ﹤0.01%
2,153
+719
+50% +$3.25K
WSBK
4155
Winchester Bancorp
WSBK
$116M
$5.74K ﹤0.01%
+641
New +$5.9K
MURA
4156
DELISTED
Mural Oncology
MURA
$5.72K ﹤0.01%
2,318
-264
-10% -$622
ETHW
4157
Bitwise Ethereum ETF
ETHW
$196M
$5.72K ﹤0.01%
317
-133
-30% -$2.1K
TPET icon
4158
Trio Petroleum
TPET
$11.4M
$5.71K ﹤0.01%
4,608
+1,329
+41% +$1.68K
LNSR icon
4159
LENSAR
LNSR
$72.5M
$5.69K ﹤0.01%
432
-582
-57% -$7.86K
LIMN
4160
Liminatus Pharma
LIMN
$7.38M
$5.66K ﹤0.01%
+508
New +$5.7K
LOCL icon
4161
Local Bounti
LOCL
$28.5M
$5.66K ﹤0.01%
2,417
+1,304
+117% +$3.22K
RMTI icon
4162
Rockwell Medical
RMTI
$27.9M
$5.66K ﹤0.01%
667
+419
+169% +$4.27K
GIPR icon
4163
Generation Income Properties
GIPR
$751K
$5.65K ﹤0.01%
387
+102
+36% +$1.56K
REBN icon
4164
Reborn Coffee
REBN
$12.2M
$5.64K ﹤0.01%
2,221
+1,238
+126% +$3.49K
STI icon
4165
Solidion Technology
STI
$68.3M
$5.64K ﹤0.01%
1,431
+848
+145% +$3.65K
ANTX icon
4166
AN2 Therapeutics
ANTX
$218M
$5.63K ﹤0.01%
5,313
+3,231
+155% +$3.85K
XOS icon
4167
Xos
XOS
$37.3M
$5.62K ﹤0.01%
1,861
+1,456
+360% +$4.94K
ORBS
4168
Eightco Holdings
ORBS
$277M
$5.61K ﹤0.01%
4,526
-836
-16% -$1.03K
ARKW icon
4169
ARK Web x.0 ETF
ARKW
$1.77B
$5.61K ﹤0.01%
38
-356
-90% -$40.7K
PICK icon
4170
iShares MSCI Global Metals & Mining Producers ETF
PICK
$2.33B
$5.6K ﹤0.01%
149
+120
+414% +$4.31K
FEMY icon
4171
Femasys
FEMY
$7.31M
$5.6K ﹤0.01%
290
+132
+84% +$2.77K
FATBB
4172
DELISTED
FAT Brands
FATBB
$5.57K ﹤0.01%
2,226
+1,113
+100% +$2.9K
CNSP icon
4173
CNS Pharmaceuticals
CNSP
$7.5M
$5.56K ﹤0.01%
562
+136
+32% +$1.7K
CAMP icon
4174
CAMP4 Therapeutics
CAMP
$267M
$5.55K ﹤0.01%
+3,830
New +$7.62K
APUS
4175
Apimeds Pharmaceuticals US
APUS
$6.46M
$5.55K ﹤0.01%
+315
New +$5.68K

Similar funds

Tower Research Capital (TRC)'s Q2 2025 Portfolio in Review

As of Q2 2025, Tower Research Capital (TRC) held 5,705 positions worth $3.71B, up 10% from $3.36B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Tower Research Capital (TRC)'s Q2 2025 filing shows 584 new, 2,919 increased, 1,681 reduced and 462 closed positions. Its largest new stake was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 218,270 shares worth $20M. The largest sale was Invesco QQQ Trust, an estimated $206M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • Tower Research Capital (TRC)'s largest Q2 2025 buy was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 218,270 shares worth $20M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2025, an estimated $127M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2025 reduction was Invesco QQQ Trust, cutting an estimated $206M.
  • Tower Research Capital (TRC) fully exited iShares S&P 500 Value ETF in Q2 2025, selling an estimated $6.43M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 22% of its $3.71B portfolio in Q2 2025.
  • Tower Research Capital (TRC) opened 584 new positions and closed 462 in Q2 2025.
  • Tower Research Capital (TRC)'s portfolio value rose 10% quarter-over-quarter to $3.71B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2025, filed 15 Aug 2025.